What is the recommended dose of corticosteroids, such as prednisolone, for patients with bronchitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Corticosteroid Dosing for Bronchitis

For patients with acute exacerbations of chronic bronchitis, a short course (10-15 days) of systemic corticosteroid therapy is recommended, with IV therapy for hospitalized patients and oral therapy for ambulatory patients. 1, 2

Acute Exacerbations of Chronic Bronchitis

  • For acute exacerbations, prednisolone can be administered at 1-2 mg/kg/day for 10-15 days, with dosing individualized based on disease severity 2, 3
  • Systemic corticosteroids improve lung function (FEV1) and reduce treatment failure rates during acute exacerbations 1, 2
  • A 2-week course has been shown to be equivalent to an 8-week course, suggesting shorter durations are preferable to minimize side effects 1, 2
  • The initial dose of prednisolone may vary from 5 to 60 mg per day depending on the specific disease entity and severity being treated 3

Stable Chronic Bronchitis

  • For stable chronic bronchitis, long-term maintenance therapy with oral corticosteroids such as prednisone should NOT be used due to lack of evidence for benefit and high risk of serious side effects 1, 2
  • A four-week trial with inhaled steroids did not significantly improve airway inflammation in patients with chronic bronchitis compared to placebo 4
  • Oral steroids at doses less than 10-15 mg prednisolone show no evidence to support long-term use, while higher doses (≥30 mg) may improve lung function over short periods but carry significant adverse effects 5

Treatment Based on Disease Severity

  • For patients with chronic bronchitis and an FEV1 of <50% predicted or those with frequent exacerbations, inhaled corticosteroid therapy should be offered 1, 2
  • In stable patients with chronic bronchitis, treatment with a long-acting β-agonist combined with an inhaled corticosteroid should be offered to control chronic cough 1
  • Patients with sputum eosinophilia are more likely to respond favorably to steroid therapy (7 of 9 patients with sputum eosinophilia responded to steroids in one study) 6

Common Pitfalls and Considerations

  • Mistaking acute bronchitis for an exacerbation of chronic bronchitis can lead to inappropriate steroid use - systemic corticosteroids are not justified in the treatment of acute bronchitis in healthy adults 7
  • Mucolytic agents may be considered as an alternative or adjunct therapy for patients with chronic bronchitis, especially those not already receiving inhaled corticosteroids 8
  • Corticosteroids can cause significant side effects with prolonged use, including hyperglycemia, adrenal suppression, osteoporosis, and immunosuppression 2, 5

Treatment Algorithm for Corticosteroid Use in Bronchitis

  1. For acute exacerbations of chronic bronchitis:

    • Start with prednisolone 30-40 mg daily for 10-15 days 1, 2
    • IV therapy for hospitalized patients, oral therapy for ambulatory patients 1, 2
    • No need to taper dose for short-term therapy 2
  2. For stable chronic bronchitis:

    • Avoid long-term oral corticosteroids 1, 5
    • Consider inhaled corticosteroids only if FEV1 <50% predicted or frequent exacerbations 1
    • Consider combination therapy with long-acting β-agonist plus inhaled corticosteroid for persistent symptoms 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Steroid Therapy for Chronic Bronchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral corticosteroids for stable chronic obstructive pulmonary disease.

The Cochrane database of systematic reviews, 2005

Research

Response to corticosteroids in chronic bronchitis.

The Journal of allergy and clinical immunology, 1978

Guideline

Steroids for Acute Bronchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.

The Cochrane database of systematic reviews, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.